Heather A. Wakelee, MD | Authors


Research Investigates Role of Antiangiogenic Agents and Checkpoint Inhibitors in EGFR NSCLC

August 13, 2019

Heather A. Wakelee, MD, discusses recent research investigating antiangiogenic agents and checkpoint inhibitors in the frontline for patients with EGFR-positive non—small cell lung cancer. The most promising data were demonstrated in the phase III IMpower150 trial.